Research


Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program

with Sonya Das, Contemporary Clinical Trials 62 (2017) 168–174

View abstract

Buying Cures vs. Renting Health: Financing Healthcare via Consumer Loans

with Vahid Montazerhodjat and David Weinstock, Science Translational Medicine 8(2016), 327ps6

View abstract

Dealing with Femtorisks in International Relations

with Aaron Benjamin Frank, Margaret Goud Collins, Simon A. Levin, Andrew W. Lo, Joshua Ramo, Ulf Dieckmann, Victor Kremenyukf, Arkady Kryazhimskiy, JoAnne Linnerooth-Bayer, Ben Ramalingam, J. Stapleton Roy, Donald G. Saari, Stefan Thurner, and Detlof von Winterfeldt, Proceedings of the National Academy of Sciences 111(2014), 17356–17362.

View abstract

Hedge Fund Beta Replication: A Five-Year Retrospective

with Peter A. Lee, Journal of Investment Management 12(2014), 5–18

View abstract

Accelerating Biomedical Innovation: A Case Study of the SPARK Program at Stanford University, School of Medicine

with Esther S. Kim, Paige M.C. Omura, Drug Discovery Today 22:7 (2017)

View abstract

Stop-loss Strategies with Serial Correlation, Regime Switching, and Transaction Costs

with Alexander Remorov, Journal of Financial Markets 34 (2017) 1–15

View abstract

New directions for the FDA in the 21st century

Biostatistics

View abstract

Moore’s Law Vs. Murphy’s Law in the Financial System: Who’s Winning?

Journal of Investment Management 15 (2017), 17–38.

View abstract

The Statistics of Sharpe Ratios

Financial Analysts Journal 58 (2002), 36-52

View abstract

Risk Management for Hedge Funds: Introduction and Overview

Financial Analysts Journal 57 (2001), 16-33

View abstract


Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design